4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

           Interferon-based hepatitis C virus (HCV) therapy is safe and effective among people receiving opioid substitution therapy (OST), but treatment uptake remains low. Our aim was to evaluate the impact of OST and drug use during therapy on completion, adherence, sustained virologic response (SVR12), and safety of ledipasvir/sofosbuvir ± ribavirin.

          Related collections

          Author and article information

          Journal
          Clin. Infect. Dis.
          Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
          Oxford University Press (OUP)
          1537-6591
          1058-4838
          Dec 01 2016
          : 63
          : 11
          Affiliations
          [1 ] The Kirby Institute, UNSW Australia, Sydney.
          [2 ] Center for HIV and Hepatogastroenterology, Düsseldorf, Germany.
          [3 ] Liver Unit, Department of Medicine, St Mary's Hospital, London, United Kingdom.
          [4 ] INSERM U954, Universitary Hospital of Nancy, University of Lorraine, Vandoeuvre-les-Nancy, France.
          [5 ] Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Milan, Italy.
          [6 ] Division of Infectious Diseases, University of California, San Diego.
          [7 ] Gilead Sciences, Foster City, California.
          [8 ] Gilead Sciences, Stockley Park, United Kingdom.
          Article
          ciw580
          10.1093/cid/ciw580
          27553375
          c3ce0a68-2930-4dc5-8b4c-9531bdcddd99
          History

          DAA,PWID,drug use,hepatitis C virus,opioid substitution therapy

          Comments

          Comment on this article